Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Jonchère

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JAK-STAT|September 27, 2013
STAT3 as a new autophagy regulatorBarbara Jonchère, Audrey Bélanger, Catherine Guette, et al.
Bulletin Du Cancer|January 15, 2016
[Contribution to tumor escape and chemotherapy response: A choice between senescence and apoptosis in heterogeneous tumors]Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, et al.
Oncotarget|October 21, 2015
Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosisAlexandra Vétillard, Barbara Jonchère, Marie Moreau, et al.
Cell Death & Disease|February 9, 2018
Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway in response to chemotherapyMélanie Le Duff, Julien Gouju, Barbara Jonchère, et al.
Oncotarget|January 8, 2015
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, et al.
Plos Pathogens|September 25, 2010
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinomaHélène C Laude, Barbara Jonchère, Eve Maubec, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JAK-STAT|September 27, 2013
STAT3 as a new autophagy regulatorBarbara Jonchère, Audrey Bélanger, Catherine Guette, et al.
Bulletin Du Cancer|January 15, 2016
[Contribution to tumor escape and chemotherapy response: A choice between senescence and apoptosis in heterogeneous tumors]Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, et al.
Oncotarget|October 21, 2015
Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosisAlexandra Vétillard, Barbara Jonchère, Marie Moreau, et al.
Cell Death & Disease|February 9, 2018
Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway in response to chemotherapyMélanie Le Duff, Julien Gouju, Barbara Jonchère, et al.
Oncotarget|January 8, 2015
Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, et al.
Plos Pathogens|September 25, 2010
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinomaHélène C Laude, Barbara Jonchère, Eve Maubec, et al.
Pageof 1